Iranian Pharmacists Propose New Framework for Medication Consultation Fees
In a formal communication, the head of the Iranian Pharmacists Association has presented a detailed proposal to the country’s Food and Drug Administration regarding the establishment of a tariff for professional medication consultation services provided in pharmacies.
A Formal Proposal for Service Valuation
The proposal was outlined in a letter from Dr. Shahram Kalantari Khandani, President of the Iranian Pharmacists Association, addressed to Dr. Mehdi Pirsalehi, Head of the Food and Drug Organization. The correspondence focuses on the methodology for determining a fair and structured fee for the critical advisory services that pharmacists offer to the public.
Key Considerations for a National Framework
The letter from the Pharmacists Association highlights two primary subjects for consideration in developing this new tariff system. This initiative underscores the ongoing efforts within Iran’s healthcare sector to formally recognize and standardize the value of professional pharmaceutical expertise, ensuring that patients receive high-quality guidance on their medication regimens. The move is seen as a step toward enhancing the overall structure and professionalism of the national health system.
